Aleksander Roberto Zampronio

Aleksander Roberto Zampronio

Auto-generated profile, based on publicly available information

Aleksander Roberto Zampronio

Inflammation and Fever Lab, Department of Pharmacology, Federal University of Paraná, Brazil

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2004 in British Journal of Pharmacology
Verified
Journal Article
Closed access
PDF file
JCJuliana G Chichorro
Juliana G Chichorro
BLBerenice B Lorenzetti
Berenice B Lorenzetti
AZAleksander R Zampronio
Aleksander R Zampronio

1 July 2009 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
CKCandida Kassuya
Candida Kassuya
ACAline Cremoneze
Aline Cremoneze
LBLetícia Ferrari Lemos Barros
Letícia Ferrari Lemos Barros
ASAlex Sandro Simas
Alex Sandro Simas
FLFernanda da Rocha Lapa
Fernanda da Rocha Lapa
AZAleksander Roberto Zampronio
Aleksander Roberto Zampronio

1 July 2006 in Pain
Verified
Journal Article
Closed access
JCJuliana Geremias Chichorro
Juliana Geremias Chichorro
AZAleksander Roberto Zampronio
Aleksander Roberto Zampronio
GSGloria Emilia Petto Souza
Gloria Emilia Petto Souza
GRGiles Alexander Rae
Giles Alexander Rae
The susceptibility of changes in responsiveness to noxious cold stimulation of rats submitted to chronic constriction of the infraorbital nerve (CION) or carrageenan to drug inhibition was compared. Nocifensive responses were measured as total time rats engaged in bilateral facial grooming with both forepaws over the first 2 min following tetrafluoroethane spray application to the snout. Carrageenan (50 microg, s.c. into upper lip) caused short-lived ipsilateral cold hyperalgesia (peak at 3 h: vehicle 8.4+/-1.3, carrageenan 21.2+/-3.0 s) which was markedly suppressed by i.p. indomethacin (4 mg/kg), celecoxib (10mg/kg) or s.c. dexamethasone (0.5 mg/kg), endothelin ET(A) or ET(B) receptor antagonists (BQ-123 and BQ-788, respectively; 10 nmol/lip). CION caused ipsilateral cold hyperalgesia between Days 2 and 12, which peaked on Days 4 (sham 15.3+/-1.8, CION 32.4+/-5.3s) to 6. Established peak CION-induced cold hyperalgesia was unaffected by indomethacin and celecoxib, whereas dexamethasone, BQ-123, BQ-788, and i.v. injections of selective antagonists of ET(A) (atrasentan, 3-10 mg/kg) or ET(B) (A-192621, 5-20 mg/kg) receptors caused significant inhibitions lasting 1-2.5h (peaks approximately 65-90%). Bosentan (dual ET(A)/ET(B) receptor antagonist, 10 mg/kg, i.v.) abolished CION-induced cold hyperalgesia for up to 6h. Thus, once established, CION-induced orofacial hyperalgesia to cold stimuli appears to lack an inflammatory component, but is alleviated by endothelin ET(A) and/or ET(B) receptor antagonists. If this CION injury model bears predictive value to trigeminal neuralgia (i.e., paroxysmal orofacial pain triggered by various stimuli), endothelin receptors might constitute new targets for treatment of this disorder.

10 September 2015 in Environmental Toxicology and Chemistry
Verified
Journal Article
Closed access
PDF file
JRJoão Luiz Coelho Ribas
João Luiz Coelho Ribas
AZAleksander R. Zampronio
Aleksander R. Zampronio
HAHelena Cristina Silva de Assis
Helena Cristina Silva de Assis

1 June 2013 in Neuropeptides
Verified
Journal Article
Closed access
FTFernanda C. Teodoro
Fernanda C. Teodoro
MJMarcos F. Tronco Júnior
Marcos F. Tronco Júnior
AZAleksander R. Zampronio
Aleksander R. Zampronio
AMAlessandra C. Martini
Alessandra C. Martini
GRGiles A. Rae
Giles A. Rae
JCJuliana G. Chichorro
Juliana G. Chichorro

2 October 2015 in Temperature
Verified
Journal Article
Open access
AZAleksander R Zampronio
Aleksander R Zampronio
DSDenis M Soares
Denis M Soares
GSGlória E P Souza
Glória E P Souza
Fever is a complex signal of inflammatory and infectious diseases. It is generally initiated when peripherally produced endogenous pyrogens reach areas that surround the hypothalamus. These peripheral endogenous pyrogens are cytokines that are produced by leukocytes and other cells, the most known of which are interleukin-1β, tumor necrosis factor-α, and interleukin-6. Because of the capacity of these molecules to induce their own synthesis and the synthesis of other cytokines, they can also be synthesized in the central nervous system. However, these pyrogens are not the final mediators of the febrile response. These cytokines can induce the synthesis of cyclooxygenase-2, which produces prostaglandins. These prostanoids alter hypothalamic temperature control, leading to an increase in heat production, the conservation of heat, and ultimately fever. The effect of antipyretics is based on blocking prostaglandin synthesis. In this review, we discuss recent data on the importance of prostaglandins in the febrile response, and we show that some endogenous mediators can still induce the febrile response even when known antipyretics reduce the levels of prostaglandins in the central nervous system. These studies suggest that centrally produced mediators other than prostaglandins participate in the genesis of fever. Among the most studied central mediators of fever are corticotropin-releasing factor, endothelins, chemokines, endogenous opioids, and substance P, which are discussed herein. Additionally, recent evidence suggests that these different pathways of fever induction may be activated during different pathological conditions.